(CHWY) Chewy - Overview
Sector: Consumer Cyclical | Industry: Internet Retail | Exchange: NYSE (USA) | Market Cap: 10.784m USD | Total Return: -20.2% in 12m
Avg Trading Vol: 218M USD
Peers RS (IBD): 10.0
EPS Trend: 57.9%
Qual. Beats: 0
Rev. Trend: 94.6%
Qual. Beats: 0
Chewy, Inc. (CHWY) operates as an e-commerce platform for pet products and services in the United States. The company offers a range of items including pet food, treats, supplies, medications, and health-related products.
Its business model relies on direct-to-consumer sales via retail websites and mobile applications, with a significant portion of revenue derived from its Autoship subscription program. The pet supply industry is experiencing a shift towards online retail, and subscription models help secure recurring revenue for e-commerce businesses.
Founded in 2010 and based in Plantation, Florida, Chewy operates within the Other Specialty Retail GICS sub-industry.
Further analysis of CHWYs financial performance and market position can be found on ValueRay.
- Autoship subscription growth drives recurring revenue
- Pet medication sales boost average order value
- New customer acquisition costs impact profitability
- Increased competition from brick-and-mortar retailers
- Consumer discretionary spending affects pet product demand
| Net Income: 222.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 0.64 > 1.0 |
| NWC/Revenue: -2.11% < 20% (prev -4.59%; Δ 2.48% < -1%) |
| CFO/TA 0.19 > 3% & CFO 691.6m > Net Income 222.8m |
| Net Debt (-303.3m) to EBITDA (397.2m): -0.76 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (424.1m) vs 12m ago -1.60% < -2% |
| Gross Margin: 29.52% > 18% (prev 0.29%; Δ 2.92k% > 0.5%) |
| Asset Turnover: 381.4% > 50% (prev 393.5%; Δ -12.08% > 0%) |
| Interest Coverage Ratio: 59.77 > 6 (EBITDA TTM 397.2m / Interest Expense TTM 4.49m) |
| A: -0.07 (Total Current Assets 2.04b - Total Current Liabilities 2.30b) / Total Assets 3.59b |
| B: -0.38 (Retained Earnings -1.36b / Total Assets 3.59b) |
| C: 0.08 (EBIT TTM 268.3m / Avg Total Assets 3.30b) |
| D: -0.44 (Book Value of Equity -1.35b / Total Liabilities 3.10b) |
| Altman-Z'' Score: -1.63 = D |
| DSRI: 1.24 (Receivables 222.2m/169.0m, Revenue 12.60b/11.86b) |
| GMI: 0.99 (GM 29.52% / 29.24%) |
| AQI: 1.33 (AQ_t 0.15 / AQ_t-1 0.11) |
| SGI: 1.06 (Revenue 12.60b / 11.86b) |
| TATA: -0.13 (NI 222.8m - CFO 691.6m) / TA 3.59b) |
| Beneish M-Score: -2.73 (Cap -4..+1) = A |
Over the past week, the price has changed by +2.87%, over one month by +0.11%, over three months by -16.42% and over the past year by -20.20%.
- StrongBuy: 11
- Buy: 6
- Hold: 12
- Sell: 1
- StrongSell: 0
| Wallstreet Target Price | 40.8 | 51% |
| Analysts Target Price | 40.8 | 51% |
P/E Forward = 17.0068
P/S = 0.8557
P/B = 20.6615
P/EG = 0.8802
Revenue TTM = 12.60b USD
EBIT TTM = 268.3m USD
EBITDA TTM = 397.2m USD
Long Term Debt = 518.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 38.1m USD (from shortTermDebt, last quarter)
Debt = 556.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -303.3m USD (from netDebt column, last quarter)
Enterprise Value = 10.46b USD (10.78b + Debt 556.8m - CCE 878.8m)
Interest Coverage Ratio = 59.77 (Ebit TTM 268.3m / Interest Expense TTM 4.49m)
EV/FCF = 18.60x (Enterprise Value 10.46b / FCF TTM 562.4m)
FCF Yield = 5.38% (FCF TTM 562.4m / Enterprise Value 10.46b)
FCF Margin = 4.46% (FCF TTM 562.4m / Revenue TTM 12.60b)
Net Margin = 1.77% (Net Income TTM 222.8m / Revenue TTM 12.60b)
Gross Margin = 29.52% ((Revenue TTM 12.60b - Cost of Revenue TTM 8.88b) / Revenue TTM)
Gross Margin QoQ = 28.35% (prev 29.78%)
Tobins Q-Ratio = 2.91 (Enterprise Value 10.46b / Total Assets 3.59b)
Interest Expense / Debt = 0.11% (Interest Expense 600k / Debt 556.8m)
Taxrate = 6.89% (2.90m / 42.1m)
NOPAT = 249.8m (EBIT 268.3m * (1 - 6.89%))
Current Ratio = 0.88 (Total Current Assets 2.04b / Total Current Liabilities 2.30b)
Debt / Equity = 1.12 (Debt 556.8m / totalStockholderEquity, last quarter 497.9m)
Debt / EBITDA = -0.76 (Net Debt -303.3m / EBITDA 397.2m)
Debt / FCF = -0.54 (Net Debt -303.3m / FCF TTM 562.4m)
Total Stockholder Equity = 433.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.74% (Net Income 222.8m / Total Assets 3.59b)
RoE = 51.43% (Net Income TTM 222.8m / Total Stockholder Equity 433.2m)
RoCE = 28.19% (EBIT 268.3m / Capital Employed (Equity 433.2m + L.T.Debt 518.7m))
RoIC = 57.67% (NOPAT 249.8m / Invested Capital 433.2m)
WACC = 8.76% (E(10.78b)/V(11.34b) * Re(9.21%) + D(556.8m)/V(11.34b) * Rd(0.11%) * (1-Tc(0.07)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.29%
[DCF] Terminal Value 78.47% ; FCFF base≈518.4m ; Y1≈611.7m ; Y5≈941.8m
[DCF] Fair Price = 59.95 (EV 14.10b - Net Debt -303.3m = Equity 14.40b / Shares 240.2m; r=8.76% [WACC]; 5y FCF grow 19.17% → 3.0% )
EPS Correlation: 57.87 | EPS CAGR: 56.79% | SUE: 0.31 | # QB: 0
Revenue Correlation: 94.64 | Revenue CAGR: 8.21% | SUE: -0.10 | # QB: 0
EPS next Quarter (2026-07-31): EPS=0.41 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+3 | Analysts=13
EPS current Year (2027-01-31): EPS=1.61 | Chg7d=+0.046 | Chg30d=+0.049 | Revisions Net=+10 | Growth EPS=+26.5% | Growth Revenue=+8.6%
EPS next Year (2028-01-31): EPS=1.97 | Chg7d=+0.097 | Chg30d=+0.075 | Revisions Net=+4 | Growth EPS=+22.7% | Growth Revenue=+7.9%
[Analyst] Revisions Ratio: +0.60 (4 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 9.2% - Earnings Yield 2.0%)
[Growth] Growth Spread = +1.4% (Analyst 8.6% - Implied 7.2%)